Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Short-term Investments (2024 - 2025)

PAVmed has reported Short-term Investments over the past 2 years, most recently at $299000.0 for Q3 2025.

  • Quarterly results put Short-term Investments at $299000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $299000.0 (changed N/A YoY), and the annual figure for FY2024 was $299000.0, changed.
  • Short-term Investments for Q3 2025 was $299000.0 at PAVmed, roughly flat from $299000.0 in the prior quarter.
  • Over the last five years, Short-term Investments for PAVM hit a ceiling of $299000.0 in Q4 2024 and a floor of $299000.0 in Q4 2024.